First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial

发表于 2026-7-9 19:16:21

期刊：Nature Medicine

文献作者：Shaodong Hong; Qiming Wang; Ying Cheng; Yongzhong Luo; Xiujuan Qu; Haibo Zhu; Zhenyu Ding; Xingya Li; Lin Wu; Yan Wang; Sheng Hu; Enwen Wang; Anwen Liu; Yuping Sun; Yun Fan; Feng Ye; Kaihua Lu; Jian Fang; Yuping Shen; Xiaoping Jin; Junyou Ge; Li Zhang; Wenfeng Fang

出版日期：2025-11-

DOI号：10.1038/s41591-025-03883-5

下载链接：https://www.nature.com/articles/s41591-025-03883-5.pdf

文献链接：https://doi.org/10.1038/s41591-025-03883-5

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-7-9 19:16:22

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Nature] First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Nature] First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial 一键复制

已采纳